Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
0(0%)
Results Posted
50%(5 trials)

Phase Distribution

Ph phase_3
4
33%
Ph phase_4
2
17%
Ph not_applicable
5
42%
Ph phase_2
1
8%

Phase Distribution

0

Early Stage

1

Mid Stage

6

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
1(8.3%)
Phase 3Large-scale testing
4(33.3%)
Phase 4Post-market surveillance
2(16.7%)
N/ANon-phased studies
5(41.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(10)
Other(2)

Detailed Status

Completed10
unknown2

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (8.3%)
Phase 34 (33.3%)
Phase 42 (16.7%)
N/A5 (41.7%)

Trials by Status

completed1083%
unknown217%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DEVICE
Total Trials
12